[8-K] Nutex Health, Inc. Reports Material Event

Rhea-AI Filing Summary

Nutex Health Inc. filed a current report to announce that it has released its financial and operating results for the fourth quarter and full year ended December 31, 2024. The results are provided in a press release dated November 18, 2025, which is furnished as Exhibit 99.1 to this report. The company also clarifies that the information in Item 2.02 and Exhibit 99.1 is being furnished, not filed, so it is not subject to certain liability provisions and is not automatically incorporated into other securities law filings.

0001479681FALSE00014796812025-11-182025-11-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) November 18, 2025

NUTEX HEALTH INC.

(Exact name of registrant as specified in its charter)

Delaware			001-41346			11-3363609
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

6030 S. Rice Ave, Suite C, Houston, Texas 77081

(Address of principal executive offices) (zip code)

(713) 660-0557

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbols(s)			Name of each exchange on which registered
Common Stock, $0.001 par value			NUTX			NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 2.02. Results of Operations and Financial Condition

On November 18, 2025, Nutex Health Inc. (the “Company”) announced its financial and operating results for the fourth quarter and year ending December 31, 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits

Exhibit No.			Description of Exhibit
99.1			Press Release dated November 18, 2025
104			Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

THE INFORMATION CONTAINED IN ITEM 2.02 OF THIS CURRENT REPORT, INCLUDING EXHIBIT 99.1 ATTACHED HERETO, SHALL NOT BE DEEMED “FILED” FOR THE PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, NOR SHALL IT BE DEEMED INCORPORATED BY REFERENCE INTO ANY REGISTRATION STATEMENT OR OTHER FILING PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, EXCEPT AS OTHERWISE EXPRESSLY STATED IN SUCH FILING

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 18, 2025

Nutex Health Inc.

By: /s/ Jon C. Bates

Jon C. Bates

Chief Financial Officer

FAQ

What did Nutex Health (NUTX) announce in this Form 8-K?

Nutex Health announced that it has released its financial and operating results for the fourth quarter and year ended December 31, 2024, via a press release furnished with the report.

Which period do the Nutex Health 2024 results in this 8-K cover?

The results cover the fourth quarter and the full fiscal year ended December 31, 2024.

Where can investors find the detailed 2024 results for Nutex Health?

Detailed results are contained in Exhibit 99.1, a press release dated November 18, 2025, which is furnished with this Form 8-K.

Is the Nutex Health 2024 earnings press release considered filed with the SEC?

No. The company states that the information in Item 2.02 and Exhibit 99.1 is furnished, not filed, under the Securities Exchange Act of 1934.

Which exchange does Nutex Health common stock trade on and under what symbol?

Nutex Health common stock trades on the NASDAQ Stock Market LLC under the trading symbol NUTX.

Who signed the Nutex Health Form 8-K announcing the 2024 results?

The report was signed on November 18, 2025 by Jon C. Bates, the company’s Chief Financial Officer.